Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Annovis Bio, Inc. (ANVS)

12.07   0.73 (6.44%) 07-02 16:39
Open: 11.54 Pre. Close: 11.34
High: 12.1999 Low: 11.364
Volume: 50,406 Market Cap: 99(M)
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.21 - 12.27 12.27 - 12.33
Low: 11.23 - 11.29 11.29 - 11.35
Close: 11.97 - 12.07 12.07 - 12.17

Technical analysis

as of: 2022-07-01 4:20:03 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 16.72     One year: 19.53
Support: Support1: 11.01    Support2: 8.97
Resistance: Resistance1: 14.31    Resistance2: 16.72
Pivot: 10.98
Moving Average: MA(5): 11.86     MA(20): 11.2
MA(100): 11.92     MA(250): 25.41
MACD: MACD(12,26): 0.3     Signal(9): 0.2
Stochastic oscillator: %K(14,3): 51.9     %D(3): 51.4
RSI: RSI(14): 57
52-week: High: 132  Low: 8.39
Average Vol(K): 3-Month: 41 (K)  10-Days: 38 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ ANVS ] has closed below upper band by 14.2%. Bollinger Bands are 4.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 29 Jun 2022
Annovis Bio, Inc.'s (NYSE:ANVS) 25% gain last week benefited both individual investors who own 58% as well as insiders - Simply Wall St

Tue, 28 Jun 2022
Thermal Night Vision System Market 2022 Analysis by Top Manufacturers – FLIR, Speedir NightRide, THEON SENSORS, Opgal – Designer Women - Designer Women

Tue, 14 Jun 2022
Annovis Bio Submits International Patent Application - MyChesCo

Mon, 06 Jun 2022
Will Annovis Bio Inc (ANVS) Outperform the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver

Sun, 05 Jun 2022
Atreca (NASDAQ:BCEL) & Annovis Bio (NYSE:ANVS) Critical Analysis - Defense World

Mon, 02 May 2022
LADENBURG THALM/SH SH Initiates Coverage on Annovis Bio (NYSE:ANVS) - Defense World

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 8 (M)
Shares Float 6 (M)
% Held by Insiders 30.9 (%)
% Held by Institutions 15.5 (%)
Shares Short 180 (K)
Shares Short P.Month 221 (K)

Stock Financials

EPS -2.18
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 5.15
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -43.8
Return on Equity (ttm) -74.1
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow -10 (M)
Levered Free Cash Flow -3 (M)

Stock Valuations

PE Ratio -5.57
PEG Ratio 0
Price to Book value 2.34
Price to Sales 0
Price to Cash Flow -10.18

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.